NFKB1 and coronary artery disorder: In order to determine whether vitamin D can reduce vascular inflammation and atherosclerosis by suppression of the NF-κB pathway and be used as a potential treatment agent for CAD in patients with hypovitaminosis D, this review will define CAD and its risk factors, pathophysiology, symptoms and treatment.